Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice

Experimental Biology and Medicine

Volumn 236, Issue 3, 2011, Pages 315-324

  Kamata, Hirofumi ^a   Tasaka, Sadatomo ^a   Inoue, Ken Ichiro ^b   Miyamoto, Keisuke ^a   Nakano, Yasushi ^a   Shinoda, Hiromi ^a   Kimizuka, Yoshifumi ^a   Fujiwara, Hiroshi ^a   Ishii, Makoto ^a   Hasegawa, Naoki ^a   Takamiya, Rina ^a   Fujishima, Seitaro ^a   Takano, Hirohisa ^b   Ishizaka, Akitoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Bleomycin; Lung inflammation; Nanoparticle; Oxidant injury; Pulmonary fibrosis

Indexed keywords

3 NITROTYROSINE; BLEOMYCIN; CARBON BLACK NANOPARTICLE; COLLAGEN; INTERLEUKIN 6; KERATINOCYTE CHEMOATTRACTANT; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AIRBORNE PARTICLE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; FEMALE; HEALTH HAZARD; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN EXPRESSION; RISK FACTOR;

ANIMALS; BLEOMYCIN; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FIBROSIS; HISTOCYTOCHEMISTRY; INFLAMMATION; LUNG; LUNG DISEASES; MICE; MICE, INBRED C57BL; MICROSCOPY; NANOPARTICLES; SOOT;

MUS;

EID: 79953203624     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010180     Document Type: Article

References (38)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64
2. Kinnula VL, Fattman CL, Tan RJ, Oury TD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005;172:417-22 (Pubitemid 41117386)
3. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 2006;3:364-72 (Pubitemid 43845414)
4. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999;159:373-82 (Pubitemid 29084854)
5. Cohen AJ, Pope CA III. Lung cancer and air pollution. Environ Health Perspect 1995;103 (Suppl. 8):219-24 (Pubitemid 26040903)
6. Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753-9 (Pubitemid 23355547)
7. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, Stewart-Evans J, Malliarou E, Jarup L, Harrington R, Svartengren M, Han IK, Ohman-Strickland P, Chung KF, Zhang J. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med 2007;357:2348-58 (Pubitemid 350223389)
8. Anderson HR, Ponce de Leon A, Bland JM, Bower JS, Emberlin J, Strachan DP. Air pollution, pollens, and daily admissions for asthma in London 1987-92. Thorax 1998;53:842-8
9. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 2006;295:1127-34 (Pubitemid 43352341)
10. Anderson HR, Spix C, Medina S, Schouten JP, Castellsague J, Rossi G, Zmirou D, Touloumi G, Wojtyniak B, Ponka A, Bacharova L, Schwartz J, Katsouyanni K. Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J 1997;10:1064-71 (Pubitemid 27201811)
11. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311:622-7 (Pubitemid 43191298)
12. Cyrys J, Stolzel M, Heinrich J, Kreyling WG, Menzel N, Wittmaack K, Tuch T, Wichmann HE. Elemental composition and sources of fine and ultrafine ambient particles in Erfurt, Germany. Sci Total Environ 2003;305:143-56 (Pubitemid 36379048)
13. Oberdorster G, Utell MJ. Ultrafine particles in the urban air: to the respiratory tract - and beyond? Environ Health Perspect 2002;110:A440-1
14. Peters A,Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Crit Care Med 1997;155:1376-83 (Pubitemid 27172786)
15. Samet JM, Rappold A, Graff D, Cascio WE, Berntsen JH, Huang YC, Herbst M, Bassett M, Montilla T, Hazucha MJ, Bromberg PA, Devlin RB. Concentrated ambient ultrafine particle exposure induces cardiac changes in young healthy volunteers. Am J Respir Crit Care Med 2009;179:1034-42
16. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001;74:1-8 (Pubitemid 32123735)
17. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001;175:191-9 (Pubitemid 32917742)
18. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005;2:10
19. Inoue K, Takano H, Yanagisawa R, Sakurai M, Ichinose T, Sadakane K, Yoshikawa T. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 2005;6:106
20. Inoue K, Takano H, Yanagisawa R, Hirano S, Sakurai M, Shimada A, Yoshikawa T. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ Health Perspect 2006;114:1325-30 (Pubitemid 44314752)
21. Saito F, Tasaka S, Inoue KI, Miyamoto K, Nakano Y, Ogawa Y, Yamada W, Shiraishi Y, Hasegawa N, Fujishima S, Takano H, Ishizaka A. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 2008;38:566-71 (Pubitemid 351758675)
22. Inoue K, Takano H, Kaewamatawong T, Shimada A, Suzuki J, Yanagisawa R, Tasaka S, Ishizaka A, Satoh M. Role of metallothionein in lung inflammation induced by ozone exposure in mice. Free Radical Biol Med 2008;45:1714-22
23. Ferin J, Oberdorster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 1992;6:535-42
24. Li XY, Brown D, Smith S, MacNee W, Donaldson K. Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhalation Toxicol 1999;11:709-31 (Pubitemid 29405121)
25. Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000;16:534-54
26. Inoue K, Takano H, Yanagisawa R, Hirano S, Kobayashi T, Fujitani Y, Shimada A, Yoshikawa T. Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice. Toxicology 2007;238:99-110 (Pubitemid 47239214)
27. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;411:157-60
28. Stadtman ER, Oliver CN. Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 1991;266:2005-8 (Pubitemid 21909019)
29. Rose CE Jr, Sung SS, Fu SM. Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003;10:273-88 (Pubitemid 39004255)
30. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 1992;89:5371-5
31. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, Ando M. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 1999;14:376-82 (Pubitemid 29461305)
32. Goodwin A, Jenkins G. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans 2009;37:849-54
33. Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006;3:377-82
34. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991;5:155-62
35. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997;150:981-91
36. Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006;533:240-52 (Pubitemid 43340016)
37. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:1763-9 (Pubitemid 27216690)
38. Decologne N, Wettstein G, Kolb M, Margetts P, Garrido C, Camus P, Bonniaud P. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles. Eur Respir J 2009;35:176-85